138 related articles for article (PubMed ID: 11012149)
41. A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts.
Yang H; Eaves C; de Lima M; Lee MS; Champlin RE; McMannis JD; Robinson SN; Niu T; Decker WK; Xing D; Ng J; Li S; Yao X; Eaves AC; Jones R; Andersson BS; Shpall EJ
Bone Marrow Transplant; 2006 Mar; 37(6):575-82. PubMed ID: 16435011
[TBL] [Abstract][Full Text] [Related]
42. Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors.
Angstreich GR; Matsui W; Huff CA; Vala MS; Barber J; Hawkins AL; Griffin CA; Smith BD; Jones RJ
Br J Haematol; 2005 Aug; 130(3):373-81. PubMed ID: 16042686
[TBL] [Abstract][Full Text] [Related]
43. Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level.
Udomsakdi C; Eaves CJ; Swolin B; Reid DS; Barnett MJ; Eaves AC
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6192-6. PubMed ID: 1631107
[TBL] [Abstract][Full Text] [Related]
44. Growth control in leukemia.
Eaves AC; Eaves CJ
Prog Clin Biol Res; 1990; 354A():223-36. PubMed ID: 2247489
[TBL] [Abstract][Full Text] [Related]
45. The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: evidence for an indirect mechanism.
Cashman JD; Eaves AC; Eaves CJ
Blood; 1994 Sep; 84(5):1534-42. PubMed ID: 8068944
[TBL] [Abstract][Full Text] [Related]
46. Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia.
Holyoake T; Jiang X; Eaves C; Eaves A
Blood; 1999 Sep; 94(6):2056-64. PubMed ID: 10477735
[TBL] [Abstract][Full Text] [Related]
47. Multilineage outgrowth of both malignant and normal hemopoietic progenitor cells from individual chronic myeloid leukemia patients in immunodeficient mice.
Verstegen MM; Cornelissen JJ; Terpstra W; Wagemaker G; Wognum AW
Leukemia; 1999 Apr; 13(4):618-28. PubMed ID: 10214871
[TBL] [Abstract][Full Text] [Related]
48. Unique differentiation programs of human fetal liver stem cells shown both in vitro and in vivo in NOD/SCID mice.
Nicolini FE; Holyoake TL; Cashman JD; Chu PP; Lambie K; Eaves CJ
Blood; 1999 Oct; 94(8):2686-95. PubMed ID: 10515872
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of optimal survival of primitive progenitor cells (LTC-IC) from PBPC apheresis products after overnight storage.
Petzer AL; Gunsilius E; Zech N; Clausen J; Hoflehner E; Nussbaumer W; Gastl G
Bone Marrow Transplant; 2000 Jan; 25(2):197-200. PubMed ID: 10673680
[TBL] [Abstract][Full Text] [Related]
50. MCP-1, not MIP-1alpha, is the endogenous chemokine that cooperates with TGF-beta to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures.
Cashman JD; Eaves CJ; Sarris AH; Eaves AC
Blood; 1998 Oct; 92(7):2338-44. PubMed ID: 9746772
[TBL] [Abstract][Full Text] [Related]
51. Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia.
Petzer AL; Eaves CJ; Lansdorp PM; Ponchio L; Barnett MJ; Eaves AC
Blood; 1996 Sep; 88(6):2162-71. PubMed ID: 8822936
[TBL] [Abstract][Full Text] [Related]
52. Phenotypic heterogeneity of primitive leukemic hematopoietic cells in patients with chronic myeloid leukemia.
Udomsakdi C; Eaves CJ; Lansdorp PM; Eaves AC
Blood; 1992 Nov; 80(10):2522-30. PubMed ID: 1384787
[TBL] [Abstract][Full Text] [Related]
53. Differential growth patterns in SCID mice of patient-derived chronic myelogenous leukemias.
McGuirk J; Yan Y; Childs B; Fernandez J; Barnett L; Jagiello C; Collins N; O'Reilly RJ
Bone Marrow Transplant; 1998 Aug; 22(4):367-74. PubMed ID: 9722072
[TBL] [Abstract][Full Text] [Related]
54. [Experimental systems in CML biology].
Maru Y
Nihon Rinsho; 2001 Dec; 59(12):2322-8. PubMed ID: 11766333
[TBL] [Abstract][Full Text] [Related]
55. Regulation of hemopoietic progenitor cell proliferation.
Eaves CJ; Eaves AC
Behring Inst Mitt; 1988 Aug; (83):85-92. PubMed ID: 3240226
[TBL] [Abstract][Full Text] [Related]
56. Abnormal erythropoiesis in the myeloproliferative disorders: an analysis of underlying cellular and humoral mechanisms.
Eaves AC; Henkelman DH; Eaves CJ
Exp Hematol; 1980; 8 Suppl 8():235-47. PubMed ID: 6962070
[TBL] [Abstract][Full Text] [Related]
57. Normal and chronic phase CML hematopoietic cells repopulate NOD/SCID bone marrow with different kinetics and cell lineage representation.
Dazzi F; Hasserjian R; Gordon MY; Boecklin F; Cotter F; Corbo M; Capelli D; Goldman JM
Hematol J; 2000; 1(5):307-15. PubMed ID: 11920208
[TBL] [Abstract][Full Text] [Related]
58. Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia.
Bernstein ID; Singer JW; Smith FO; Andrews RG; Flowers DA; Petersens J; Steinmann L; Najfeld V; Savage D; Fruchtman S
Blood; 1992 Apr; 79(7):1811-6. PubMed ID: 1373089
[TBL] [Abstract][Full Text] [Related]
59. CD14+ peripheral blood mononuclear cells from chronic myeloid leukemia and normal donors are inhibitory to short- and long-term cultured colony-forming cells.
Heissig B; Pasternak G; Hörner S; Schwerdtfeger R; Rossol S; Hehlmann R
Leuk Res; 2000 Mar; 24(3):217-31. PubMed ID: 10739004
[TBL] [Abstract][Full Text] [Related]
60. [Analysis of chronic myeloproliferative syndromes using the technics of in vitro hematopoiesis (the origin and function of marrow stromal cells in CML)].
Takahashi M; Fujiwara M
Rinsho Ketsueki; 1988 Jul; 29(7):994-1000. PubMed ID: 3184486
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
